Global Vaccine (Include COVID-19) Supply, Demand and Key Producers, 2023-2029
The global Vaccine (Include COVID-19) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
This report studies the global Vaccine (Include COVID-19) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vaccine (Include COVID-19), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vaccine (Include COVID-19) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Vaccine (Include COVID-19) total market, 2018-2029, (USD Million)
Global Vaccine (Include COVID-19) total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Vaccine (Include COVID-19) total market, key domestic companies and share, (USD Million)
Global Vaccine (Include COVID-19) revenue by player and market share 2018-2023, (USD Million)
Global Vaccine (Include COVID-19) total market by Type, CAGR, 2018-2029, (USD Million)
Global Vaccine (Include COVID-19) total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Vaccine (Include COVID-19) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and KM Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vaccine (Include COVID-19) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Vaccine (Include COVID-19) Market, By Region:
1. How big is the global Vaccine (Include COVID-19) market?
2. What is the demand of the global Vaccine (Include COVID-19) market?
3. What is the year over year growth of the global Vaccine (Include COVID-19) market?
4. What is the total value of the global Vaccine (Include COVID-19) market?
5. Who are the major players in the global Vaccine (Include COVID-19) market?
6. What are the growth factors driving the market demand?
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
This report studies the global Vaccine (Include COVID-19) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vaccine (Include COVID-19), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vaccine (Include COVID-19) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Vaccine (Include COVID-19) total market, 2018-2029, (USD Million)
Global Vaccine (Include COVID-19) total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Vaccine (Include COVID-19) total market, key domestic companies and share, (USD Million)
Global Vaccine (Include COVID-19) revenue by player and market share 2018-2023, (USD Million)
Global Vaccine (Include COVID-19) total market by Type, CAGR, 2018-2029, (USD Million)
Global Vaccine (Include COVID-19) total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Vaccine (Include COVID-19) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and KM Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vaccine (Include COVID-19) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Vaccine (Include COVID-19) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Inactivated Vaccine
- Attenuated Vaccine
- mRNA
- Other
- Public
- Private
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- KM Biologics
- Pfizer
- Merck
- Sinovac
- Zhejiang Pukang
- Walvax Biotechnology
- Bharat Biotech
- Serum Institute
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- LG Life Sciences
1. How big is the global Vaccine (Include COVID-19) market?
2. What is the demand of the global Vaccine (Include COVID-19) market?
3. What is the year over year growth of the global Vaccine (Include COVID-19) market?
4. What is the total value of the global Vaccine (Include COVID-19) market?
5. Who are the major players in the global Vaccine (Include COVID-19) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Vaccine (Include COVID-19) Introduction
1.2 World Vaccine (Include COVID-19) Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Vaccine (Include COVID-19) Total Market by Region (by Headquarter Location)
1.3.1 World Vaccine (Include COVID-19) Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Vaccine (Include COVID-19) Market Size (2018-2029)
1.3.3 China Vaccine (Include COVID-19) Market Size (2018-2029)
1.3.4 Europe Vaccine (Include COVID-19) Market Size (2018-2029)
1.3.5 Japan Vaccine (Include COVID-19) Market Size (2018-2029)
1.3.6 South Korea Vaccine (Include COVID-19) Market Size (2018-2029)
1.3.7 ASEAN Vaccine (Include COVID-19) Market Size (2018-2029)
1.3.8 India Vaccine (Include COVID-19) Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vaccine (Include COVID-19) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vaccine (Include COVID-19) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Vaccine (Include COVID-19) Consumption Value (2018-2029)
2.2 World Vaccine (Include COVID-19) Consumption Value by Region
2.2.1 World Vaccine (Include COVID-19) Consumption Value by Region (2018-2023)
2.2.2 World Vaccine (Include COVID-19) Consumption Value Forecast by Region (2024-2029)
2.3 United States Vaccine (Include COVID-19) Consumption Value (2018-2029)
2.4 China Vaccine (Include COVID-19) Consumption Value (2018-2029)
2.5 Europe Vaccine (Include COVID-19) Consumption Value (2018-2029)
2.6 Japan Vaccine (Include COVID-19) Consumption Value (2018-2029)
2.7 South Korea Vaccine (Include COVID-19) Consumption Value (2018-2029)
2.8 ASEAN Vaccine (Include COVID-19) Consumption Value (2018-2029)
2.9 India Vaccine (Include COVID-19) Consumption Value (2018-2029)
3 WORLD VACCINE (INCLUDE COVID-19) COMPANIES COMPETITIVE ANALYSIS
3.1 World Vaccine (Include COVID-19) Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Vaccine (Include COVID-19) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Vaccine (Include COVID-19) in 2022
3.2.3 Global Concentration Ratios (CR8) for Vaccine (Include COVID-19) in 2022
3.3 Vaccine (Include COVID-19) Company Evaluation Quadrant
3.4 Vaccine (Include COVID-19) Market: Overall Company Footprint Analysis
3.4.1 Vaccine (Include COVID-19) Market: Region Footprint
3.4.2 Vaccine (Include COVID-19) Market: Company Product Type Footprint
3.4.3 Vaccine (Include COVID-19) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Vaccine (Include COVID-19) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Vaccine (Include COVID-19) Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Vaccine (Include COVID-19) Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Vaccine (Include COVID-19) Consumption Value Comparison
4.2.1 United States VS China: Vaccine (Include COVID-19) Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Vaccine (Include COVID-19) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Vaccine (Include COVID-19) Companies and Market Share, 2018-2023
4.3.1 United States Based Vaccine (Include COVID-19) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Vaccine (Include COVID-19) Revenue, (2018-2023)
4.4 China Based Companies Vaccine (Include COVID-19) Revenue and Market Share, 2018-2023
4.4.1 China Based Vaccine (Include COVID-19) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Vaccine (Include COVID-19) Revenue, (2018-2023)
4.5 Rest of World Based Vaccine (Include COVID-19) Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Vaccine (Include COVID-19) Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Vaccine (Include COVID-19) Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Vaccine (Include COVID-19) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Inactivated Vaccine
5.2.2 Attenuated Vaccine
5.2.3 mRNA
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Vaccine (Include COVID-19) Market Size by Type (2018-2023)
5.3.2 World Vaccine (Include COVID-19) Market Size by Type (2024-2029)
5.3.3 World Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Vaccine (Include COVID-19) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Public
6.2.2 Private
6.3 Market Segment by Application
6.3.1 World Vaccine (Include COVID-19) Market Size by Application (2018-2023)
6.3.2 World Vaccine (Include COVID-19) Market Size by Application (2024-2029)
6.3.3 World Vaccine (Include COVID-19) Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Vaccine (Include COVID-19) Product and Services
7.1.4 Sanofi Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 CSL
7.2.1 CSL Details
7.2.2 CSL Major Business
7.2.3 CSL Vaccine (Include COVID-19) Product and Services
7.2.4 CSL Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 CSL Recent Developments/Updates
7.2.6 CSL Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Vaccine (Include COVID-19) Product and Services
7.3.4 GSK Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Viatris
7.4.1 Viatris Details
7.4.2 Viatris Major Business
7.4.3 Viatris Vaccine (Include COVID-19) Product and Services
7.4.4 Viatris Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Viatris Recent Developments/Updates
7.4.6 Viatris Competitive Strengths & Weaknesses
7.5 AstraZeneca
7.5.1 AstraZeneca Details
7.5.2 AstraZeneca Major Business
7.5.3 AstraZeneca Vaccine (Include COVID-19) Product and Services
7.5.4 AstraZeneca Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 AstraZeneca Recent Developments/Updates
7.5.6 AstraZeneca Competitive Strengths & Weaknesses
7.6 Hualan Bio
7.6.1 Hualan Bio Details
7.6.2 Hualan Bio Major Business
7.6.3 Hualan Bio Vaccine (Include COVID-19) Product and Services
7.6.4 Hualan Bio Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Hualan Bio Recent Developments/Updates
7.6.6 Hualan Bio Competitive Strengths & Weaknesses
7.7 Changchun Institute of Biological
7.7.1 Changchun Institute of Biological Details
7.7.2 Changchun Institute of Biological Major Business
7.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Product and Services
7.7.4 Changchun Institute of Biological Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Changchun Institute of Biological Recent Developments/Updates
7.7.6 Changchun Institute of Biological Competitive Strengths & Weaknesses
7.8 Sinovac
7.8.1 Sinovac Details
7.8.2 Sinovac Major Business
7.8.3 Sinovac Vaccine (Include COVID-19) Product and Services
7.8.4 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Sinovac Recent Developments/Updates
7.8.6 Sinovac Competitive Strengths & Weaknesses
7.9 KM Biologics
7.9.1 KM Biologics Details
7.9.2 KM Biologics Major Business
7.9.3 KM Biologics Vaccine (Include COVID-19) Product and Services
7.9.4 KM Biologics Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 KM Biologics Recent Developments/Updates
7.9.6 KM Biologics Competitive Strengths & Weaknesses
7.10 Pfizer
7.10.1 Pfizer Details
7.10.2 Pfizer Major Business
7.10.3 Pfizer Vaccine (Include COVID-19) Product and Services
7.10.4 Pfizer Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Pfizer Recent Developments/Updates
7.10.6 Pfizer Competitive Strengths & Weaknesses
7.11 Merck
7.11.1 Merck Details
7.11.2 Merck Major Business
7.11.3 Merck Vaccine (Include COVID-19) Product and Services
7.11.4 Merck Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Merck Recent Developments/Updates
7.11.6 Merck Competitive Strengths & Weaknesses
7.12 Sinovac
7.12.1 Sinovac Details
7.12.2 Sinovac Major Business
7.12.3 Sinovac Vaccine (Include COVID-19) Product and Services
7.12.4 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Sinovac Recent Developments/Updates
7.12.6 Sinovac Competitive Strengths & Weaknesses
7.13 Zhejiang Pukang
7.13.1 Zhejiang Pukang Details
7.13.2 Zhejiang Pukang Major Business
7.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Product and Services
7.13.4 Zhejiang Pukang Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Zhejiang Pukang Recent Developments/Updates
7.13.6 Zhejiang Pukang Competitive Strengths & Weaknesses
7.14 Walvax Biotechnology
7.14.1 Walvax Biotechnology Details
7.14.2 Walvax Biotechnology Major Business
7.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Product and Services
7.14.4 Walvax Biotechnology Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Walvax Biotechnology Recent Developments/Updates
7.14.6 Walvax Biotechnology Competitive Strengths & Weaknesses
7.15 Bharat Biotech
7.15.1 Bharat Biotech Details
7.15.2 Bharat Biotech Major Business
7.15.3 Bharat Biotech Vaccine (Include COVID-19) Product and Services
7.15.4 Bharat Biotech Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Bharat Biotech Recent Developments/Updates
7.15.6 Bharat Biotech Competitive Strengths & Weaknesses
7.16 Serum Institute
7.16.1 Serum Institute Details
7.16.2 Serum Institute Major Business
7.16.3 Serum Institute Vaccine (Include COVID-19) Product and Services
7.16.4 Serum Institute Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Serum Institute Recent Developments/Updates
7.16.6 Serum Institute Competitive Strengths & Weaknesses
7.17 Panacea Biotec Ltd
7.17.1 Panacea Biotec Ltd Details
7.17.2 Panacea Biotec Ltd Major Business
7.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Product and Services
7.17.4 Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Panacea Biotec Ltd Recent Developments/Updates
7.17.6 Panacea Biotec Ltd Competitive Strengths & Weaknesses
7.18 Bio-Med
7.18.1 Bio-Med Details
7.18.2 Bio-Med Major Business
7.18.3 Bio-Med Vaccine (Include COVID-19) Product and Services
7.18.4 Bio-Med Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Bio-Med Recent Developments/Updates
7.18.6 Bio-Med Competitive Strengths & Weaknesses
7.19 Halfkin Bio-Pharmaceuticals
7.19.1 Halfkin Bio-Pharmaceuticals Details
7.19.2 Halfkin Bio-Pharmaceuticals Major Business
7.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product and Services
7.19.4 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7.19.6 Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
7.20 LG Life Sciences
7.20.1 LG Life Sciences Details
7.20.2 LG Life Sciences Major Business
7.20.3 LG Life Sciences Vaccine (Include COVID-19) Product and Services
7.20.4 LG Life Sciences Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 LG Life Sciences Recent Developments/Updates
7.20.6 LG Life Sciences Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Vaccine (Include COVID-19) Industry Chain
8.2 Vaccine (Include COVID-19) Upstream Analysis
8.3 Vaccine (Include COVID-19) Midstream Analysis
8.4 Vaccine (Include COVID-19) Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Vaccine (Include COVID-19) Introduction
1.2 World Vaccine (Include COVID-19) Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Vaccine (Include COVID-19) Total Market by Region (by Headquarter Location)
1.3.1 World Vaccine (Include COVID-19) Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Vaccine (Include COVID-19) Market Size (2018-2029)
1.3.3 China Vaccine (Include COVID-19) Market Size (2018-2029)
1.3.4 Europe Vaccine (Include COVID-19) Market Size (2018-2029)
1.3.5 Japan Vaccine (Include COVID-19) Market Size (2018-2029)
1.3.6 South Korea Vaccine (Include COVID-19) Market Size (2018-2029)
1.3.7 ASEAN Vaccine (Include COVID-19) Market Size (2018-2029)
1.3.8 India Vaccine (Include COVID-19) Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vaccine (Include COVID-19) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vaccine (Include COVID-19) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Vaccine (Include COVID-19) Consumption Value (2018-2029)
2.2 World Vaccine (Include COVID-19) Consumption Value by Region
2.2.1 World Vaccine (Include COVID-19) Consumption Value by Region (2018-2023)
2.2.2 World Vaccine (Include COVID-19) Consumption Value Forecast by Region (2024-2029)
2.3 United States Vaccine (Include COVID-19) Consumption Value (2018-2029)
2.4 China Vaccine (Include COVID-19) Consumption Value (2018-2029)
2.5 Europe Vaccine (Include COVID-19) Consumption Value (2018-2029)
2.6 Japan Vaccine (Include COVID-19) Consumption Value (2018-2029)
2.7 South Korea Vaccine (Include COVID-19) Consumption Value (2018-2029)
2.8 ASEAN Vaccine (Include COVID-19) Consumption Value (2018-2029)
2.9 India Vaccine (Include COVID-19) Consumption Value (2018-2029)
3 WORLD VACCINE (INCLUDE COVID-19) COMPANIES COMPETITIVE ANALYSIS
3.1 World Vaccine (Include COVID-19) Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Vaccine (Include COVID-19) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Vaccine (Include COVID-19) in 2022
3.2.3 Global Concentration Ratios (CR8) for Vaccine (Include COVID-19) in 2022
3.3 Vaccine (Include COVID-19) Company Evaluation Quadrant
3.4 Vaccine (Include COVID-19) Market: Overall Company Footprint Analysis
3.4.1 Vaccine (Include COVID-19) Market: Region Footprint
3.4.2 Vaccine (Include COVID-19) Market: Company Product Type Footprint
3.4.3 Vaccine (Include COVID-19) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Vaccine (Include COVID-19) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Vaccine (Include COVID-19) Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Vaccine (Include COVID-19) Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Vaccine (Include COVID-19) Consumption Value Comparison
4.2.1 United States VS China: Vaccine (Include COVID-19) Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Vaccine (Include COVID-19) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Vaccine (Include COVID-19) Companies and Market Share, 2018-2023
4.3.1 United States Based Vaccine (Include COVID-19) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Vaccine (Include COVID-19) Revenue, (2018-2023)
4.4 China Based Companies Vaccine (Include COVID-19) Revenue and Market Share, 2018-2023
4.4.1 China Based Vaccine (Include COVID-19) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Vaccine (Include COVID-19) Revenue, (2018-2023)
4.5 Rest of World Based Vaccine (Include COVID-19) Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Vaccine (Include COVID-19) Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Vaccine (Include COVID-19) Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Vaccine (Include COVID-19) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Inactivated Vaccine
5.2.2 Attenuated Vaccine
5.2.3 mRNA
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Vaccine (Include COVID-19) Market Size by Type (2018-2023)
5.3.2 World Vaccine (Include COVID-19) Market Size by Type (2024-2029)
5.3.3 World Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Vaccine (Include COVID-19) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Public
6.2.2 Private
6.3 Market Segment by Application
6.3.1 World Vaccine (Include COVID-19) Market Size by Application (2018-2023)
6.3.2 World Vaccine (Include COVID-19) Market Size by Application (2024-2029)
6.3.3 World Vaccine (Include COVID-19) Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Vaccine (Include COVID-19) Product and Services
7.1.4 Sanofi Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 CSL
7.2.1 CSL Details
7.2.2 CSL Major Business
7.2.3 CSL Vaccine (Include COVID-19) Product and Services
7.2.4 CSL Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 CSL Recent Developments/Updates
7.2.6 CSL Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Vaccine (Include COVID-19) Product and Services
7.3.4 GSK Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Viatris
7.4.1 Viatris Details
7.4.2 Viatris Major Business
7.4.3 Viatris Vaccine (Include COVID-19) Product and Services
7.4.4 Viatris Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Viatris Recent Developments/Updates
7.4.6 Viatris Competitive Strengths & Weaknesses
7.5 AstraZeneca
7.5.1 AstraZeneca Details
7.5.2 AstraZeneca Major Business
7.5.3 AstraZeneca Vaccine (Include COVID-19) Product and Services
7.5.4 AstraZeneca Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 AstraZeneca Recent Developments/Updates
7.5.6 AstraZeneca Competitive Strengths & Weaknesses
7.6 Hualan Bio
7.6.1 Hualan Bio Details
7.6.2 Hualan Bio Major Business
7.6.3 Hualan Bio Vaccine (Include COVID-19) Product and Services
7.6.4 Hualan Bio Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Hualan Bio Recent Developments/Updates
7.6.6 Hualan Bio Competitive Strengths & Weaknesses
7.7 Changchun Institute of Biological
7.7.1 Changchun Institute of Biological Details
7.7.2 Changchun Institute of Biological Major Business
7.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Product and Services
7.7.4 Changchun Institute of Biological Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Changchun Institute of Biological Recent Developments/Updates
7.7.6 Changchun Institute of Biological Competitive Strengths & Weaknesses
7.8 Sinovac
7.8.1 Sinovac Details
7.8.2 Sinovac Major Business
7.8.3 Sinovac Vaccine (Include COVID-19) Product and Services
7.8.4 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Sinovac Recent Developments/Updates
7.8.6 Sinovac Competitive Strengths & Weaknesses
7.9 KM Biologics
7.9.1 KM Biologics Details
7.9.2 KM Biologics Major Business
7.9.3 KM Biologics Vaccine (Include COVID-19) Product and Services
7.9.4 KM Biologics Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 KM Biologics Recent Developments/Updates
7.9.6 KM Biologics Competitive Strengths & Weaknesses
7.10 Pfizer
7.10.1 Pfizer Details
7.10.2 Pfizer Major Business
7.10.3 Pfizer Vaccine (Include COVID-19) Product and Services
7.10.4 Pfizer Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Pfizer Recent Developments/Updates
7.10.6 Pfizer Competitive Strengths & Weaknesses
7.11 Merck
7.11.1 Merck Details
7.11.2 Merck Major Business
7.11.3 Merck Vaccine (Include COVID-19) Product and Services
7.11.4 Merck Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Merck Recent Developments/Updates
7.11.6 Merck Competitive Strengths & Weaknesses
7.12 Sinovac
7.12.1 Sinovac Details
7.12.2 Sinovac Major Business
7.12.3 Sinovac Vaccine (Include COVID-19) Product and Services
7.12.4 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Sinovac Recent Developments/Updates
7.12.6 Sinovac Competitive Strengths & Weaknesses
7.13 Zhejiang Pukang
7.13.1 Zhejiang Pukang Details
7.13.2 Zhejiang Pukang Major Business
7.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Product and Services
7.13.4 Zhejiang Pukang Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Zhejiang Pukang Recent Developments/Updates
7.13.6 Zhejiang Pukang Competitive Strengths & Weaknesses
7.14 Walvax Biotechnology
7.14.1 Walvax Biotechnology Details
7.14.2 Walvax Biotechnology Major Business
7.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Product and Services
7.14.4 Walvax Biotechnology Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Walvax Biotechnology Recent Developments/Updates
7.14.6 Walvax Biotechnology Competitive Strengths & Weaknesses
7.15 Bharat Biotech
7.15.1 Bharat Biotech Details
7.15.2 Bharat Biotech Major Business
7.15.3 Bharat Biotech Vaccine (Include COVID-19) Product and Services
7.15.4 Bharat Biotech Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Bharat Biotech Recent Developments/Updates
7.15.6 Bharat Biotech Competitive Strengths & Weaknesses
7.16 Serum Institute
7.16.1 Serum Institute Details
7.16.2 Serum Institute Major Business
7.16.3 Serum Institute Vaccine (Include COVID-19) Product and Services
7.16.4 Serum Institute Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Serum Institute Recent Developments/Updates
7.16.6 Serum Institute Competitive Strengths & Weaknesses
7.17 Panacea Biotec Ltd
7.17.1 Panacea Biotec Ltd Details
7.17.2 Panacea Biotec Ltd Major Business
7.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Product and Services
7.17.4 Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Panacea Biotec Ltd Recent Developments/Updates
7.17.6 Panacea Biotec Ltd Competitive Strengths & Weaknesses
7.18 Bio-Med
7.18.1 Bio-Med Details
7.18.2 Bio-Med Major Business
7.18.3 Bio-Med Vaccine (Include COVID-19) Product and Services
7.18.4 Bio-Med Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Bio-Med Recent Developments/Updates
7.18.6 Bio-Med Competitive Strengths & Weaknesses
7.19 Halfkin Bio-Pharmaceuticals
7.19.1 Halfkin Bio-Pharmaceuticals Details
7.19.2 Halfkin Bio-Pharmaceuticals Major Business
7.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product and Services
7.19.4 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7.19.6 Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
7.20 LG Life Sciences
7.20.1 LG Life Sciences Details
7.20.2 LG Life Sciences Major Business
7.20.3 LG Life Sciences Vaccine (Include COVID-19) Product and Services
7.20.4 LG Life Sciences Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 LG Life Sciences Recent Developments/Updates
7.20.6 LG Life Sciences Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Vaccine (Include COVID-19) Industry Chain
8.2 Vaccine (Include COVID-19) Upstream Analysis
8.3 Vaccine (Include COVID-19) Midstream Analysis
8.4 Vaccine (Include COVID-19) Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Vaccine (Include COVID-19) Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Vaccine (Include COVID-19) Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Vaccine (Include COVID-19) Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Vaccine (Include COVID-19) Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Vaccine (Include COVID-19) Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Vaccine (Include COVID-19) Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Vaccine (Include COVID-19) Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Vaccine (Include COVID-19) Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Vaccine (Include COVID-19) Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Vaccine (Include COVID-19) Players in 2022
Table 12. World Vaccine (Include COVID-19) Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Vaccine (Include COVID-19) Company Evaluation Quadrant
Table 14. Head Office of Key Vaccine (Include COVID-19) Player
Table 15. Vaccine (Include COVID-19) Market: Company Product Type Footprint
Table 16. Vaccine (Include COVID-19) Market: Company Product Application Footprint
Table 17. Vaccine (Include COVID-19) Mergers & Acquisitions Activity
Table 18. United States VS China Vaccine (Include COVID-19) Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Vaccine (Include COVID-19) Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Vaccine (Include COVID-19) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Vaccine (Include COVID-19) Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Vaccine (Include COVID-19) Revenue Market Share (2018-2023)
Table 23. China Based Vaccine (Include COVID-19) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Vaccine (Include COVID-19) Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Vaccine (Include COVID-19) Revenue Market Share (2018-2023)
Table 26. Rest of World Based Vaccine (Include COVID-19) Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Vaccine (Include COVID-19) Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Vaccine (Include COVID-19) Revenue Market Share (2018-2023)
Table 29. World Vaccine (Include COVID-19) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Vaccine (Include COVID-19) Market Size by Type (2018-2023) & (USD Million)
Table 31. World Vaccine (Include COVID-19) Market Size by Type (2024-2029) & (USD Million)
Table 32. World Vaccine (Include COVID-19) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Vaccine (Include COVID-19) Market Size by Application (2018-2023) & (USD Million)
Table 34. World Vaccine (Include COVID-19) Market Size by Application (2024-2029) & (USD Million)
Table 35. Sanofi Basic Information, Area Served and Competitors
Table 36. Sanofi Major Business
Table 37. Sanofi Vaccine (Include COVID-19) Product and Services
Table 38. Sanofi Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Sanofi Recent Developments/Updates
Table 40. Sanofi Competitive Strengths & Weaknesses
Table 41. CSL Basic Information, Area Served and Competitors
Table 42. CSL Major Business
Table 43. CSL Vaccine (Include COVID-19) Product and Services
Table 44. CSL Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. CSL Recent Developments/Updates
Table 46. CSL Competitive Strengths & Weaknesses
Table 47. GSK Basic Information, Area Served and Competitors
Table 48. GSK Major Business
Table 49. GSK Vaccine (Include COVID-19) Product and Services
Table 50. GSK Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. GSK Recent Developments/Updates
Table 52. GSK Competitive Strengths & Weaknesses
Table 53. Viatris Basic Information, Area Served and Competitors
Table 54. Viatris Major Business
Table 55. Viatris Vaccine (Include COVID-19) Product and Services
Table 56. Viatris Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Viatris Recent Developments/Updates
Table 58. Viatris Competitive Strengths & Weaknesses
Table 59. AstraZeneca Basic Information, Area Served and Competitors
Table 60. AstraZeneca Major Business
Table 61. AstraZeneca Vaccine (Include COVID-19) Product and Services
Table 62. AstraZeneca Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. AstraZeneca Recent Developments/Updates
Table 64. AstraZeneca Competitive Strengths & Weaknesses
Table 65. Hualan Bio Basic Information, Area Served and Competitors
Table 66. Hualan Bio Major Business
Table 67. Hualan Bio Vaccine (Include COVID-19) Product and Services
Table 68. Hualan Bio Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Hualan Bio Recent Developments/Updates
Table 70. Hualan Bio Competitive Strengths & Weaknesses
Table 71. Changchun Institute of Biological Basic Information, Area Served and Competitors
Table 72. Changchun Institute of Biological Major Business
Table 73. Changchun Institute of Biological Vaccine (Include COVID-19) Product and Services
Table 74. Changchun Institute of Biological Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Changchun Institute of Biological Recent Developments/Updates
Table 76. Changchun Institute of Biological Competitive Strengths & Weaknesses
Table 77. Sinovac Basic Information, Area Served and Competitors
Table 78. Sinovac Major Business
Table 79. Sinovac Vaccine (Include COVID-19) Product and Services
Table 80. Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Sinovac Recent Developments/Updates
Table 82. Sinovac Competitive Strengths & Weaknesses
Table 83. KM Biologics Basic Information, Area Served and Competitors
Table 84. KM Biologics Major Business
Table 85. KM Biologics Vaccine (Include COVID-19) Product and Services
Table 86. KM Biologics Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. KM Biologics Recent Developments/Updates
Table 88. KM Biologics Competitive Strengths & Weaknesses
Table 89. Pfizer Basic Information, Area Served and Competitors
Table 90. Pfizer Major Business
Table 91. Pfizer Vaccine (Include COVID-19) Product and Services
Table 92. Pfizer Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Pfizer Recent Developments/Updates
Table 94. Pfizer Competitive Strengths & Weaknesses
Table 95. Merck Basic Information, Area Served and Competitors
Table 96. Merck Major Business
Table 97. Merck Vaccine (Include COVID-19) Product and Services
Table 98. Merck Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Merck Recent Developments/Updates
Table 100. Merck Competitive Strengths & Weaknesses
Table 101. Sinovac Basic Information, Area Served and Competitors
Table 102. Sinovac Major Business
Table 103. Sinovac Vaccine (Include COVID-19) Product and Services
Table 104. Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Sinovac Recent Developments/Updates
Table 106. Sinovac Competitive Strengths & Weaknesses
Table 107. Zhejiang Pukang Basic Information, Area Served and Competitors
Table 108. Zhejiang Pukang Major Business
Table 109. Zhejiang Pukang Vaccine (Include COVID-19) Product and Services
Table 110. Zhejiang Pukang Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Zhejiang Pukang Recent Developments/Updates
Table 112. Zhejiang Pukang Competitive Strengths & Weaknesses
Table 113. Walvax Biotechnology Basic Information, Area Served and Competitors
Table 114. Walvax Biotechnology Major Business
Table 115. Walvax Biotechnology Vaccine (Include COVID-19) Product and Services
Table 116. Walvax Biotechnology Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Walvax Biotechnology Recent Developments/Updates
Table 118. Walvax Biotechnology Competitive Strengths & Weaknesses
Table 119. Bharat Biotech Basic Information, Area Served and Competitors
Table 120. Bharat Biotech Major Business
Table 121. Bharat Biotech Vaccine (Include COVID-19) Product and Services
Table 122. Bharat Biotech Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Bharat Biotech Recent Developments/Updates
Table 124. Bharat Biotech Competitive Strengths & Weaknesses
Table 125. Serum Institute Basic Information, Area Served and Competitors
Table 126. Serum Institute Major Business
Table 127. Serum Institute Vaccine (Include COVID-19) Product and Services
Table 128. Serum Institute Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Serum Institute Recent Developments/Updates
Table 130. Serum Institute Competitive Strengths & Weaknesses
Table 131. Panacea Biotec Ltd Basic Information, Area Served and Competitors
Table 132. Panacea Biotec Ltd Major Business
Table 133. Panacea Biotec Ltd Vaccine (Include COVID-19) Product and Services
Table 134. Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Panacea Biotec Ltd Recent Developments/Updates
Table 136. Panacea Biotec Ltd Competitive Strengths & Weaknesses
Table 137. Bio-Med Basic Information, Area Served and Competitors
Table 138. Bio-Med Major Business
Table 139. Bio-Med Vaccine (Include COVID-19) Product and Services
Table 140. Bio-Med Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Bio-Med Recent Developments/Updates
Table 142. Bio-Med Competitive Strengths & Weaknesses
Table 143. Halfkin Bio-Pharmaceuticals Basic Information, Area Served and Competitors
Table 144. Halfkin Bio-Pharmaceuticals Major Business
Table 145. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product and Services
Table 146. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 148. LG Life Sciences Basic Information, Area Served and Competitors
Table 149. LG Life Sciences Major Business
Table 150. LG Life Sciences Vaccine (Include COVID-19) Product and Services
Table 151. LG Life Sciences Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Vaccine (Include COVID-19) Upstream (Raw Materials)
Table 153. Vaccine (Include COVID-19) Typical Customers
Table 1. World Vaccine (Include COVID-19) Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Vaccine (Include COVID-19) Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Vaccine (Include COVID-19) Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Vaccine (Include COVID-19) Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Vaccine (Include COVID-19) Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Vaccine (Include COVID-19) Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Vaccine (Include COVID-19) Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Vaccine (Include COVID-19) Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Vaccine (Include COVID-19) Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Vaccine (Include COVID-19) Players in 2022
Table 12. World Vaccine (Include COVID-19) Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Vaccine (Include COVID-19) Company Evaluation Quadrant
Table 14. Head Office of Key Vaccine (Include COVID-19) Player
Table 15. Vaccine (Include COVID-19) Market: Company Product Type Footprint
Table 16. Vaccine (Include COVID-19) Market: Company Product Application Footprint
Table 17. Vaccine (Include COVID-19) Mergers & Acquisitions Activity
Table 18. United States VS China Vaccine (Include COVID-19) Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Vaccine (Include COVID-19) Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Vaccine (Include COVID-19) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Vaccine (Include COVID-19) Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Vaccine (Include COVID-19) Revenue Market Share (2018-2023)
Table 23. China Based Vaccine (Include COVID-19) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Vaccine (Include COVID-19) Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Vaccine (Include COVID-19) Revenue Market Share (2018-2023)
Table 26. Rest of World Based Vaccine (Include COVID-19) Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Vaccine (Include COVID-19) Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Vaccine (Include COVID-19) Revenue Market Share (2018-2023)
Table 29. World Vaccine (Include COVID-19) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Vaccine (Include COVID-19) Market Size by Type (2018-2023) & (USD Million)
Table 31. World Vaccine (Include COVID-19) Market Size by Type (2024-2029) & (USD Million)
Table 32. World Vaccine (Include COVID-19) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Vaccine (Include COVID-19) Market Size by Application (2018-2023) & (USD Million)
Table 34. World Vaccine (Include COVID-19) Market Size by Application (2024-2029) & (USD Million)
Table 35. Sanofi Basic Information, Area Served and Competitors
Table 36. Sanofi Major Business
Table 37. Sanofi Vaccine (Include COVID-19) Product and Services
Table 38. Sanofi Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Sanofi Recent Developments/Updates
Table 40. Sanofi Competitive Strengths & Weaknesses
Table 41. CSL Basic Information, Area Served and Competitors
Table 42. CSL Major Business
Table 43. CSL Vaccine (Include COVID-19) Product and Services
Table 44. CSL Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. CSL Recent Developments/Updates
Table 46. CSL Competitive Strengths & Weaknesses
Table 47. GSK Basic Information, Area Served and Competitors
Table 48. GSK Major Business
Table 49. GSK Vaccine (Include COVID-19) Product and Services
Table 50. GSK Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. GSK Recent Developments/Updates
Table 52. GSK Competitive Strengths & Weaknesses
Table 53. Viatris Basic Information, Area Served and Competitors
Table 54. Viatris Major Business
Table 55. Viatris Vaccine (Include COVID-19) Product and Services
Table 56. Viatris Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Viatris Recent Developments/Updates
Table 58. Viatris Competitive Strengths & Weaknesses
Table 59. AstraZeneca Basic Information, Area Served and Competitors
Table 60. AstraZeneca Major Business
Table 61. AstraZeneca Vaccine (Include COVID-19) Product and Services
Table 62. AstraZeneca Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. AstraZeneca Recent Developments/Updates
Table 64. AstraZeneca Competitive Strengths & Weaknesses
Table 65. Hualan Bio Basic Information, Area Served and Competitors
Table 66. Hualan Bio Major Business
Table 67. Hualan Bio Vaccine (Include COVID-19) Product and Services
Table 68. Hualan Bio Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Hualan Bio Recent Developments/Updates
Table 70. Hualan Bio Competitive Strengths & Weaknesses
Table 71. Changchun Institute of Biological Basic Information, Area Served and Competitors
Table 72. Changchun Institute of Biological Major Business
Table 73. Changchun Institute of Biological Vaccine (Include COVID-19) Product and Services
Table 74. Changchun Institute of Biological Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Changchun Institute of Biological Recent Developments/Updates
Table 76. Changchun Institute of Biological Competitive Strengths & Weaknesses
Table 77. Sinovac Basic Information, Area Served and Competitors
Table 78. Sinovac Major Business
Table 79. Sinovac Vaccine (Include COVID-19) Product and Services
Table 80. Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Sinovac Recent Developments/Updates
Table 82. Sinovac Competitive Strengths & Weaknesses
Table 83. KM Biologics Basic Information, Area Served and Competitors
Table 84. KM Biologics Major Business
Table 85. KM Biologics Vaccine (Include COVID-19) Product and Services
Table 86. KM Biologics Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. KM Biologics Recent Developments/Updates
Table 88. KM Biologics Competitive Strengths & Weaknesses
Table 89. Pfizer Basic Information, Area Served and Competitors
Table 90. Pfizer Major Business
Table 91. Pfizer Vaccine (Include COVID-19) Product and Services
Table 92. Pfizer Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Pfizer Recent Developments/Updates
Table 94. Pfizer Competitive Strengths & Weaknesses
Table 95. Merck Basic Information, Area Served and Competitors
Table 96. Merck Major Business
Table 97. Merck Vaccine (Include COVID-19) Product and Services
Table 98. Merck Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Merck Recent Developments/Updates
Table 100. Merck Competitive Strengths & Weaknesses
Table 101. Sinovac Basic Information, Area Served and Competitors
Table 102. Sinovac Major Business
Table 103. Sinovac Vaccine (Include COVID-19) Product and Services
Table 104. Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Sinovac Recent Developments/Updates
Table 106. Sinovac Competitive Strengths & Weaknesses
Table 107. Zhejiang Pukang Basic Information, Area Served and Competitors
Table 108. Zhejiang Pukang Major Business
Table 109. Zhejiang Pukang Vaccine (Include COVID-19) Product and Services
Table 110. Zhejiang Pukang Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Zhejiang Pukang Recent Developments/Updates
Table 112. Zhejiang Pukang Competitive Strengths & Weaknesses
Table 113. Walvax Biotechnology Basic Information, Area Served and Competitors
Table 114. Walvax Biotechnology Major Business
Table 115. Walvax Biotechnology Vaccine (Include COVID-19) Product and Services
Table 116. Walvax Biotechnology Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Walvax Biotechnology Recent Developments/Updates
Table 118. Walvax Biotechnology Competitive Strengths & Weaknesses
Table 119. Bharat Biotech Basic Information, Area Served and Competitors
Table 120. Bharat Biotech Major Business
Table 121. Bharat Biotech Vaccine (Include COVID-19) Product and Services
Table 122. Bharat Biotech Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Bharat Biotech Recent Developments/Updates
Table 124. Bharat Biotech Competitive Strengths & Weaknesses
Table 125. Serum Institute Basic Information, Area Served and Competitors
Table 126. Serum Institute Major Business
Table 127. Serum Institute Vaccine (Include COVID-19) Product and Services
Table 128. Serum Institute Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Serum Institute Recent Developments/Updates
Table 130. Serum Institute Competitive Strengths & Weaknesses
Table 131. Panacea Biotec Ltd Basic Information, Area Served and Competitors
Table 132. Panacea Biotec Ltd Major Business
Table 133. Panacea Biotec Ltd Vaccine (Include COVID-19) Product and Services
Table 134. Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Panacea Biotec Ltd Recent Developments/Updates
Table 136. Panacea Biotec Ltd Competitive Strengths & Weaknesses
Table 137. Bio-Med Basic Information, Area Served and Competitors
Table 138. Bio-Med Major Business
Table 139. Bio-Med Vaccine (Include COVID-19) Product and Services
Table 140. Bio-Med Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Bio-Med Recent Developments/Updates
Table 142. Bio-Med Competitive Strengths & Weaknesses
Table 143. Halfkin Bio-Pharmaceuticals Basic Information, Area Served and Competitors
Table 144. Halfkin Bio-Pharmaceuticals Major Business
Table 145. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product and Services
Table 146. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 148. LG Life Sciences Basic Information, Area Served and Competitors
Table 149. LG Life Sciences Major Business
Table 150. LG Life Sciences Vaccine (Include COVID-19) Product and Services
Table 151. LG Life Sciences Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Vaccine (Include COVID-19) Upstream (Raw Materials)
Table 153. Vaccine (Include COVID-19) Typical Customers
LIST OF FIGURES
Figure 1. Vaccine (Include COVID-19) Picture
Figure 2. World Vaccine (Include COVID-19) Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Vaccine (Include COVID-19) Total Market Size (2018-2029) & (USD Million)
Figure 4. World Vaccine (Include COVID-19) Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Vaccine (Include COVID-19) Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Vaccine (Include COVID-19) Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Vaccine (Include COVID-19) Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Vaccine (Include COVID-19) Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Vaccine (Include COVID-19) Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Vaccine (Include COVID-19) Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Vaccine (Include COVID-19) Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Vaccine (Include COVID-19) Revenue (2018-2029) & (USD Million)
Figure 13. Vaccine (Include COVID-19) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 16. World Vaccine (Include COVID-19) Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 18. China Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 23. India Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Vaccine (Include COVID-19) by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Vaccine (Include COVID-19) Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Vaccine (Include COVID-19) Markets in 2022
Figure 27. United States VS China: Vaccine (Include COVID-19) Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Vaccine (Include COVID-19) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Vaccine (Include COVID-19) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Vaccine (Include COVID-19) Market Size Market Share by Type in 2022
Figure 31. Inactivated Vaccine
Figure 32. Attenuated Vaccine
Figure 33. mRNA
Figure 34. Other
Figure 35. World Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2029)
Figure 36. World Vaccine (Include COVID-19) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Vaccine (Include COVID-19) Market Size Market Share by Application in 2022
Figure 38. Public
Figure 39. Private
Figure 40. Vaccine (Include COVID-19) Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Vaccine (Include COVID-19) Picture
Figure 2. World Vaccine (Include COVID-19) Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Vaccine (Include COVID-19) Total Market Size (2018-2029) & (USD Million)
Figure 4. World Vaccine (Include COVID-19) Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Vaccine (Include COVID-19) Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Vaccine (Include COVID-19) Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Vaccine (Include COVID-19) Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Vaccine (Include COVID-19) Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Vaccine (Include COVID-19) Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Vaccine (Include COVID-19) Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Vaccine (Include COVID-19) Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Vaccine (Include COVID-19) Revenue (2018-2029) & (USD Million)
Figure 13. Vaccine (Include COVID-19) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 16. World Vaccine (Include COVID-19) Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 18. China Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 23. India Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Vaccine (Include COVID-19) by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Vaccine (Include COVID-19) Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Vaccine (Include COVID-19) Markets in 2022
Figure 27. United States VS China: Vaccine (Include COVID-19) Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Vaccine (Include COVID-19) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Vaccine (Include COVID-19) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Vaccine (Include COVID-19) Market Size Market Share by Type in 2022
Figure 31. Inactivated Vaccine
Figure 32. Attenuated Vaccine
Figure 33. mRNA
Figure 34. Other
Figure 35. World Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2029)
Figure 36. World Vaccine (Include COVID-19) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Vaccine (Include COVID-19) Market Size Market Share by Application in 2022
Figure 38. Public
Figure 39. Private
Figure 40. Vaccine (Include COVID-19) Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
